IceCure Medical Book Value Per Share Growth & History (ICCM)
IceCure Medical's book value per share was $0.12 for fiscal 2025.
View full IceCure Medical company overviewIceCure Medical annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0.12 | $0.00 | +1.46% |
| 2024 | 2024-12-31 | $0.12 | -$0.14 | −54.13% |
| 2023 | 2023-12-31 | $0.27 | -$0.29 | −52.27% |
| 2022 | 2022-12-31 | $0.56 | -$0.20 | −26.04% |
| 2021 | 2021-12-31 | $0.75 | $0.47 | +169.71% |
| 2020 | 2020-12-31 | $0.28 | $0.04 | +15.62% |
| 2019 | 2019-12-31 | $0.24 | — | — |
IceCure Medical quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.47 | $3.42 | +6948.40% |
| Q1 2026 | 2026-03-31 | $3.14 | $0.13 | +4.18% |
| Q4 2025 | 2025-12-31 | $0.12 | $0.00 | +1.46% |
| Q3 2025 | 2025-09-30 | $4.05 | — | — |
| Q2 2025 | 2025-06-30 | $0.05 | -$0.17 | −77.01% |
| Q1 2025 | 2025-03-31 | $3.01 | — | — |
| Q4 2024 | 2024-12-31 | $0.12 | -$0.14 | −54.13% |
| Q2 2024 | 2024-06-30 | $0.21 | -$0.19 | −46.98% |
| Q4 2023 | 2023-12-31 | $0.27 | -$0.29 | −52.27% |
| Q2 2023 | 2023-06-30 | $0.40 | -$0.11 | −21.18% |
| Q4 2022 | 2022-12-31 | $0.56 | -$0.20 | −26.04% |
| Q2 2022 | 2022-06-30 | $0.51 | — | — |
| Q4 2021 | 2021-12-31 | $0.75 | — | — |
IceCure Medical book value per share trends
Over the last five fiscal years, IceCure Medical's book value per share decreased from $0.28 to $0.12, a change of -$0.16. The latest reported quarter, Q2 2026, shows $3.47.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IceCure Medical source filings ↗